230 related articles for article (PubMed ID: 34292224)
1. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS OF CLASSIC CHOROIDAL NEOVASCULARIZATION IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Izumi T; Koizumi H; Maruko I; Hasegawa T; Iida T
Retina; 2022 Jan; 42(1):123-128. PubMed ID: 34292224
[TBL] [Abstract][Full Text] [Related]
2. MORPHOLOGIC FEATURES ASSOCIATED WITH FIBROTIC SCARRING AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Kim JH; Chang YS; Kim JW; Kim CG; Lee DW; Kim YJ
Retina; 2018 Nov; 38(11):2168-2176. PubMed ID: 28930802
[TBL] [Abstract][Full Text] [Related]
3. Association between the arm-to-choroidal circulation time and clinical profile in patients with polypoidal choroidal vasculopathy.
Mukai R; Itagaki K; Honjyo J; Tanaka K; Norikawa K; Sekiryu T
Jpn J Ophthalmol; 2024 May; 68(3):211-215. PubMed ID: 38609716
[TBL] [Abstract][Full Text] [Related]
4. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.
Tan ACS; Jordan-Yu JM; Vyas CH; Gan ATL; Teo KYC; Chan CM; Mathur R; Wong TY; Chakravarthy U; Cheung GCM
Retina; 2022 Jan; 42(1):114-122. PubMed ID: 34412103
[TBL] [Abstract][Full Text] [Related]
5. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
Inoue M; Balaratnasingam C; Freund KB
Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
[TBL] [Abstract][Full Text] [Related]
6. Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
Chaikitmongkol V; Upaphong P; Patikulsila D; Jirarattanasopa P; Choovuthayakorn J; Watanachai N; Kunavisarut P; Ratanasukon M; Bhurayanontachai P; Ingviya T; Bressler SB; Bressler NM
Ophthalmol Retina; 2022 Jan; 6(1):21-28. PubMed ID: 33781929
[TBL] [Abstract][Full Text] [Related]
7. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
Kokame GT; Omizo JN; Kokame KA; Yamane ML
Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
[TBL] [Abstract][Full Text] [Related]
8. Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes.
Hwang HJ; Kim JH; Chang YS; Kim JW; Kim CG
Korean J Ophthalmol; 2017 Jun; 31(3):230-239. PubMed ID: 28534339
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Brolucizumab in Polyp Regression of Treatment-Naive Polypoidal Choroidal Vasculopathy and Its Effect on 1-Year Treatment Outcome.
Lee SH; Park HS; Han JW
Korean J Ophthalmol; 2024 Jun; 38(3):185-193. PubMed ID: 38584441
[TBL] [Abstract][Full Text] [Related]
10. POSTTREATMENT POLYP REGRESSION AND RISK OF MASSIVE SUBMACULAR HEMORRHAGE IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Cho JH; Park YJ; Cho SC; Ryoo NK; Cho KH; Park SJ; Park KH; Woo SJ
Retina; 2020 Mar; 40(3):468-476. PubMed ID: 30422938
[TBL] [Abstract][Full Text] [Related]
11. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
[TBL] [Abstract][Full Text] [Related]
12. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography.
Wang M; Zhou Y; Gao SS; Liu W; Huang Y; Huang D; Jia Y
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT526-32. PubMed ID: 27472276
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
[TBL] [Abstract][Full Text] [Related]
15. Subretinal Hyperreflective Material (SHRM) as biomarker of activity in Exudative and Non- exudative inflammatory choroidal neovascularization.
Arora A; Agarwal A; Bansal R; Katoch D; Marchese A; Aggarwal K; Agrawal R; Gupta V
Ocul Immunol Inflamm; 2023 Jan; 31(1):48-55. PubMed ID: 34648411
[TBL] [Abstract][Full Text] [Related]
16. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
[TBL] [Abstract][Full Text] [Related]
17. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X
JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817
[TBL] [Abstract][Full Text] [Related]
18. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
Zhao XY; Xia S; Luo MY; Wang EQ; Chen YX
Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
[TBL] [Abstract][Full Text] [Related]
19. COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Teo KYC; Yanagi Y; Lee SY; Yeo IYS; Tan GSW; Mathur R; Chan CM; Wong TY; Cheung CMG
Retina; 2018 Sep; 38(9):1675-1687. PubMed ID: 28767554
[TBL] [Abstract][Full Text] [Related]
20. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
